Serum complement determinations in patients with quiescent systemic lupus erythematosus

Area of Science:

• Immunology
• Rheumatology
• Clinical Medicine

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
• Identifying predictors of morbidity in inactive SLE is crucial for patient management.
• Complement system activation is implicated in SLE pathogenesis.

Purpose of the Study:

• To assess if complement component analyses during inactive SLE can identify patient subgroups.
• To determine the predictive value of complement levels for morbidity in SLE.
• To investigate the relationship between complement levels and clinical outcomes in quiescent SLE.

Main Methods:

• Analysis of 277 SLE patients with clinically inactive disease.
• Serum samples tested for total complement activity (CH100) and complement components (C1q, C1r, C1s, C3, C4).
• Correlation of complement levels with demographic data and clinical outcomes over a mean follow-up of 4.25 years.

Main Results:

• 9% of patients had multiple low complement determinations; 8.5% had a single very low complement component.
• Patients with multiple low complement levels showed a significantly higher risk of developing renal insufficiency compared to normocomplementemic controls.
• Complement component levels generally did not reflect or predict the overall clinical course of SLE.

Conclusions:

• Complement component analyses during inactive SLE have limited utility in predicting long-term outcomes.
• Multiple low complement component determinations during quiescent SLE are associated with an increased risk of renal insufficiency.
• Further research may explore the specific role of low complement levels in predicting renal complications in SLE.